Breaking News Instant updates and real-time market news.

BYSI

BeyondSpring

$27.55

0.33 (1.21%)

07:19
05/17/18
05/17
07:19
05/17/18
07:19

BeyondSpring to present prospective Phase 2/3 trial of Plinabulin at ASCO

BeyondSpring announced that the company will present results of the Phase 2 portion of Study 105, a prospective Phase 2/3 trial of its lead asset, Plinabulin, during a poster presentation at the American Society of Clinical Oncology, or ASCO, Annual Meeting on June 4, 2018. Importantly, data from the study demonstrated that patients treated with Plinabulin dosed 30 minutes after docetaxel for the prevention of docetaxel chemotherapy-induced neutropenia, or CIN, reported less bone pain, which was clinically meaningful, and had superior neutrophil counts and comparable neutropenia reduction compared to patients treated with Neulasta 24 hours after docetaxel. These findings suggest that Plinabulin has the potential for an overall superior product profile in the prevention of CIN.

BYSI BeyondSpring
$27.55

0.33 (1.21%)

10/26/17
HCWC
10/26/17
NO CHANGE
Target $60
HCWC
Buy
BeyondSpring price target raised to $60 from $50 at H.C. Wainwright
H.C. Wainwright analyst Joseph Pantginis raised his price target for BeyondSpring to $60 saying new regulatory rules in China may accelerate Plinabulin approval. The CPC Central Committee and State Council of China's new regulatory guidelines should be beneficial to BeyondSpring by accelerating approval and extending intellectual property protection, Pantginis tells investors in a research note. He keeps a Buy rating o the shares.
12/05/17
GHSC
12/05/17
INITIATION
Target $56
GHSC
Buy
BeyondSpring initiated with a Buy at Seaport Global
Seaport Global analyst Vernon Bernardino initiated BeyondSpring with a Buy and $56 price target saying its lead drug, Plinabulin, is a differentiated standard in the potential treatment option for chemotherapy-induced neutropenia (CIN). He thinks Plinabulin could also play a key role in improving results with traditional cancer drugs and immunotherapies that are limited by their significant toxicities.
03/01/18
HCWC
03/01/18
NO CHANGE
Target $60
HCWC
Buy
BeyondSpring recent selloff unwarranted, says H.C. Wainwright
H.C. Wainwright analyst Joseph Pantginis views the 17.5% selloff in shares of BeyondSpring since the February 21 announced departure of CFO Richard Brand as unwarranted. After speaking to management, the analyst believes a new CFO will be a positive as the company moves closer to pivotal data and potential commercialization of Plinabulin. He keeps a Buy rating on BeyondSpring with a $60 price target.
03/19/18
HCWC
03/19/18
NO CHANGE
HCWC
BeyondSpring 'hits ground running' with Phase 3 study, says H.C. Wainwright
H.C. Wainwright analyst Joseph Pantginis noted that BeyondSpring just announced the initiation of its Phase 3 Study 105 non-inferiority head-to-head study of Plinabulin compared to Neulasta for prevention of docetaxel chemotherapy induced neutropenia. Pantginis sees a possible Plinabulin NDA filing with the China Food and Drug Administration within one year, and maintained a Buy rating and $60 price target on BeyondSpring shares.

TODAY'S FREE FLY STORIES

COST

Costco

$227.35

1.68 (0.74%)

07:26
08/21/18
08/21
07:26
08/21/18
07:26
Recommendations
Costco analyst commentary  »

Costco price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Oct

LB

L Brands

$33.07

0.53 (1.63%)

07:26
08/21/18
08/21
07:26
08/21/18
07:26
Recommendations
L Brands analyst commentary  »

L Brands price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

MGM

MGM Resorts

$28.59

0.035 (0.12%)

, CZR

Caesars

$10.05

0.05 (0.50%)

07:25
08/21/18
08/21
07:25
08/21/18
07:25
Recommendations
MGM Resorts, Caesars analyst commentary  »

Room survey suggests…

MGM

MGM Resorts

$28.59

0.035 (0.12%)

CZR

Caesars

$10.05

0.05 (0.50%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LII

Lennox

$225.37

2.76 (1.24%)

07:24
08/21/18
08/21
07:24
08/21/18
07:24
Initiation
Lennox initiated  »

Lennox initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

HCSG

Healthcare Services

$41.33

0.11 (0.27%)

07:23
08/21/18
08/21
07:23
08/21/18
07:23
Conference/Events
Healthcare Services management to meet with Benchmark »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Aug

  • 29

    Aug

GTT

GTT Communications

$38.30

-0.7 (-1.79%)

07:23
08/21/18
08/21
07:23
08/21/18
07:23
Recommendations
GTT Communications analyst commentary  »

GTT Communications should…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FOE

Ferro

$21.23

-0.06 (-0.28%)

07:22
08/21/18
08/21
07:22
08/21/18
07:22
Conference/Events
Ferro management to meet with KeyBanc »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Aug

  • 11

    Sep

TSS

TSYS

$94.88

-0.01 (-0.01%)

07:21
08/21/18
08/21
07:21
08/21/18
07:21
Recommendations
TSYS analyst commentary  »

TSYS price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Sep

  • 17

    Sep

  • 06

    Nov

FITB

Fifth Third

$29.83

0.145 (0.49%)

07:21
08/21/18
08/21
07:21
08/21/18
07:21
Conference/Events
Fifth Third management to meet with Wedbush »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Aug

  • 23

    Oct

YRCW

YRC Worldwide

$9.11

0.11 (1.22%)

07:21
08/21/18
08/21
07:21
08/21/18
07:21
Conference/Events
YRC Worldwide management to meet with Deutsche Bank »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 06

    Nov

MDT

Medtronic

$90.06

-0.54 (-0.60%)

07:20
08/21/18
08/21
07:20
08/21/18
07:20
Hot Stocks
Breaking Hot Stocks news story on Medtronic »

Medtronic up 4.4% to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 23

    Aug

  • 05

    Sep

  • 12

    Sep

ECOM

ChannelAdvisor

$12.95

-0.15 (-1.15%)

07:20
08/21/18
08/21
07:20
08/21/18
07:20
Conference/Events
ChannelAdvisor management to meet with KeyBanc »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 23

    Aug

  • 28

    Aug

  • 06

    Sep

  • 07

    Sep

JCI

Johnson Controls

$38.73

0.48 (1.25%)

07:20
08/21/18
08/21
07:20
08/21/18
07:20
Upgrade
Johnson Controls rating change  »

Johnson Controls upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JPM

JPMorgan

$114.62

-0.13 (-0.11%)

07:19
08/21/18
08/21
07:19
08/21/18
07:19
Periodicals
JPMorgan to launch new investing app for free, CNBC reports »

JPMorgan has plans to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Oct

  • 26

    Feb

DLB

Dolby

$68.32

-0.75 (-1.09%)

07:19
08/21/18
08/21
07:19
08/21/18
07:19
Conference/Events
Dolby management to meet with William Blair »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 28

    Aug

  • 06

    Sep

EPAM

Epam Systems

$136.36

1.355 (1.00%)

07:18
08/21/18
08/21
07:18
08/21/18
07:18
Recommendations
Epam Systems analyst commentary  »

Epam Systems price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRZO

Carrizo Oil & Gas

$22.79

0.05 (0.22%)

07:17
08/21/18
08/21
07:17
08/21/18
07:17
Conference/Events
Carrizo Oil & Gas management to meet with Stephens »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Aug

BBY

Best Buy

$79.39

0.91 (1.16%)

, AMZN

Amazon.com

$1,875.45

-6.49 (-0.34%)

07:17
08/21/18
08/21
07:17
08/21/18
07:17
Recommendations
Best Buy, Amazon.com analyst commentary  »

Best Buy valuation…

BBY

Best Buy

$79.39

0.91 (1.16%)

AMZN

Amazon.com

$1,875.45

-6.49 (-0.34%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Aug

  • 13

    Sep

ACRS

Aclaris Therapeutics

$16.01

0.34 (2.17%)

07:17
08/21/18
08/21
07:17
08/21/18
07:17
Hot Stocks
Aclaris Therapeutics announces ATI-450 findings in publication »

Aclaris Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

USB

U.S. Bancorp

$53.81

0.51 (0.96%)

07:17
08/21/18
08/21
07:17
08/21/18
07:17
Recommendations
U.S. Bancorp analyst commentary  »

U.S. Bancorp capital…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRON

Cronos Group

$7.33

0.78 (11.91%)

07:16
08/21/18
08/21
07:16
08/21/18
07:16
Hot Stocks
Cronos Group announces initial supply agreement for retail distribution »

Cronos Group announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HOME

At Home Group

$34.01

0.06 (0.18%)

07:15
08/21/18
08/21
07:15
08/21/18
07:15
Recommendations
At Home Group analyst commentary  »

At Home Group's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Aug

AZPN

Aspen Technology

$107.56

-0.21 (-0.19%)

07:15
08/21/18
08/21
07:15
08/21/18
07:15
Recommendations
Aspen Technology analyst commentary  »

Aspen Technology price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

07:15
08/21/18
08/21
07:15
08/21/18
07:15
General news
Treasury Market Outlook: Treasury yields are higher »

Treasury Market Outlook:…

NEO

NeoGenomics

$12.85

0.165 (1.30%)

07:15
08/21/18
08/21
07:15
08/21/18
07:15
Initiation
NeoGenomics initiated  »

NeoGenomics initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 25

    Sep

  • 06

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.